KR100353303B1 - 항균활성을갖는고리형헥사펩티드 - Google Patents

항균활성을갖는고리형헥사펩티드 Download PDF

Info

Publication number
KR100353303B1
KR100353303B1 KR1019970702213A KR19970702213A KR100353303B1 KR 100353303 B1 KR100353303 B1 KR 100353303B1 KR 1019970702213 A KR1019970702213 A KR 1019970702213A KR 19970702213 A KR19970702213 A KR 19970702213A KR 100353303 B1 KR100353303 B1 KR 100353303B1
Authority
KR
South Korea
Prior art keywords
alkoxy
phenyl
alkyl
substituted
alkanoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019970702213A
Other languages
English (en)
Korean (ko)
Other versions
KR970707150A (ko
Inventor
히데노리 오키
마사키 도미시마
아키라 야마다
히사시 다카스기
Original Assignee
후지사와 야꾸힝 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26305774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100353303(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9420425A external-priority patent/GB9420425D0/en
Priority claimed from GBGB9508745.8A external-priority patent/GB9508745D0/en
Application filed by 후지사와 야꾸힝 고교 가부시키가이샤 filed Critical 후지사와 야꾸힝 고교 가부시키가이샤
Publication of KR970707150A publication Critical patent/KR970707150A/ko
Application granted granted Critical
Publication of KR100353303B1 publication Critical patent/KR100353303B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
KR1019970702213A 1994-10-07 1995-09-29 항균활성을갖는고리형헥사펩티드 Expired - Lifetime KR100353303B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9420425.2 1994-10-07
GB9420425A GB9420425D0 (en) 1994-10-07 1994-10-07 New compound
GBGB9508745.8A GB9508745D0 (en) 1995-04-28 1995-04-28 New compound
GB9508745.8 1995-04-28

Publications (2)

Publication Number Publication Date
KR970707150A KR970707150A (ko) 1997-12-01
KR100353303B1 true KR100353303B1 (ko) 2003-01-15

Family

ID=26305774

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970702213A Expired - Lifetime KR100353303B1 (ko) 1994-10-07 1995-09-29 항균활성을갖는고리형헥사펩티드

Country Status (26)

Country Link
US (2) US6107458A (cg-RX-API-DMAC10.html)
EP (1) EP0788511B1 (cg-RX-API-DMAC10.html)
JP (2) JP2897427B2 (cg-RX-API-DMAC10.html)
KR (1) KR100353303B1 (cg-RX-API-DMAC10.html)
CN (1) CN1203089C (cg-RX-API-DMAC10.html)
AR (1) AR041770A1 (cg-RX-API-DMAC10.html)
AT (1) ATE229541T1 (cg-RX-API-DMAC10.html)
AU (1) AU696949B2 (cg-RX-API-DMAC10.html)
BR (2) BR9504791B1 (cg-RX-API-DMAC10.html)
CA (1) CA2202058C (cg-RX-API-DMAC10.html)
DE (2) DE69529172T2 (cg-RX-API-DMAC10.html)
DK (1) DK0788511T3 (cg-RX-API-DMAC10.html)
ES (1) ES2187575T3 (cg-RX-API-DMAC10.html)
FI (1) FI119988B (cg-RX-API-DMAC10.html)
FR (1) FR08C0028I2 (cg-RX-API-DMAC10.html)
HU (1) HU228151B1 (cg-RX-API-DMAC10.html)
IL (1) IL115484A (cg-RX-API-DMAC10.html)
LU (1) LU91452I2 (cg-RX-API-DMAC10.html)
MX (1) MX9702531A (cg-RX-API-DMAC10.html)
NL (1) NL300352I2 (cg-RX-API-DMAC10.html)
NO (2) NO328483B1 (cg-RX-API-DMAC10.html)
OA (1) OA10475A (cg-RX-API-DMAC10.html)
PT (1) PT788511E (cg-RX-API-DMAC10.html)
RU (1) RU2165423C2 (cg-RX-API-DMAC10.html)
TR (1) TR199501229A2 (cg-RX-API-DMAC10.html)
WO (1) WO1996011210A1 (cg-RX-API-DMAC10.html)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
EP0994101A4 (en) * 1997-06-18 2002-05-02 Fujisawa Pharmaceutical Co NEW PREPARATION PROCESS
US6232290B1 (en) * 1998-02-09 2001-05-15 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides with antimicrobial activity
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound
EP1156787B1 (en) * 1999-02-11 2005-11-30 Emisphere Technologies, Inc. Oxadiazole compounds and compositions for delivering active agents
US7084279B1 (en) * 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
AUPP999799A0 (en) * 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
CA2380176A1 (en) 1999-07-27 2001-02-01 Aventis Pharma Deutschland Gmbh Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
TWI250992B (en) * 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
ES2191516B1 (es) * 2000-07-28 2005-01-01 Consejo Superior De Investigaciones Cientificas Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos.
AUPQ938700A0 (en) * 2000-08-14 2000-09-07 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
KR100777169B1 (ko) 2001-01-29 2007-11-16 시오노기세이야쿠가부시키가이샤 5-메틸-1-페닐-2-(1h)-피리돈을 활성 성분으로서함유하는 의약 제제
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
JP4784093B2 (ja) * 2002-08-08 2011-09-28 アステラス製薬株式会社 イソオキサゾリル安息香酸の製造法
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
WO2005018743A1 (en) 2003-07-22 2005-03-03 Theravance, Inc. Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
US20070010655A1 (en) * 2003-09-05 2007-01-11 Antia Firoz D Stationary phases and a purification process using the stationary phases
EP1669350B1 (en) * 2003-09-22 2012-02-29 Msd K.K. Piperidine derivatives
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
CN101198598A (zh) * 2004-05-20 2008-06-11 弗尔德里克斯制药股份有限公司 2-((杂)芳基)-苯并噁唑化合物及其衍生物、组合物以及用于稳定和抑制甲状腺素转运蛋白错重叠的方法
CA2580856A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
CA2580855A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580845A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
EP1799667B1 (en) 2004-09-20 2013-03-20 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
EP1804799B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1830837B1 (en) 2004-09-20 2013-09-04 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
WO2006044456A1 (en) * 2004-10-13 2006-04-27 Ptc Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
MX2007015216A (es) 2005-06-03 2008-02-22 Xenon Pharmaceuticals Inc Derivados de aminotiazol y sus usos como agentes terapeuticos.
WO2007043400A1 (ja) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
EP2184989B1 (en) 2007-08-13 2015-05-06 Monsanto Technology LLC Compositions and methods for controlling nematodes
RU2470939C2 (ru) * 2007-10-29 2012-12-27 Астеллас Фарма Инк. Полипептидное соединение
US8034806B2 (en) 2007-11-02 2011-10-11 Vanderbilt University Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
US8362050B2 (en) * 2008-06-24 2013-01-29 Irm Llc Compounds and methods for modulating G protein-coupled receptors
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
BR112013023531A2 (pt) 2011-04-04 2016-12-06 Xellia Pharmaceuticals Aps processo de um único vaso para a fabricação de micafungina ou de um sal desta
US9132163B2 (en) 2011-04-20 2015-09-15 Xellia Pharmaceuticals Aps Method for purification of Micafungin
CN102775476B (zh) * 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
EP2709609B1 (en) 2011-05-17 2017-10-04 Shionogi & Co., Ltd. Heterocyclic compounds
KR20140069097A (ko) * 2011-09-09 2014-06-09 산도즈 아게 미카펀진 중간체의 제조
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102659930B (zh) 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
JP7109189B2 (ja) * 2014-05-29 2022-07-29 シャンハイ テックウェル バイオファーマシューティカル カンパニー リミテッド シクロペプチド系化合物の組成物およびその製造方法と使用
JP6491325B2 (ja) * 2014-05-29 2019-03-27 シャンハイ テックウェル バイオファーマシューティカル カンパニー リミテッドShanghai Techwell Biopharmaceutical Co.,Ltd シクロペプチド系化合物の溶媒和物およびその製造方法と使用
EP3226885A4 (en) * 2014-10-07 2018-07-18 Alaparthi, Lakshmi Prasad Intermediates and processes to prepare micafungin
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
AU2017376960B2 (en) 2016-12-16 2023-12-14 Baxter Healthcare Sa Micafungin compositions
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin
CN108752430B (zh) * 2018-05-31 2022-02-18 杭州中美华东制药有限公司 米卡芬净钠新晶型及其制备方法
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ptp-1b阻害剤およびその用途
CN110734408A (zh) * 2019-10-22 2020-01-31 重庆康乐制药有限公司 一种米卡芬净类衍生物侧链中间体的制备方法
CN115785226A (zh) * 2021-09-09 2023-03-14 上海天伟生物制药有限公司 一种棘白菌素药物杂质及其制备、纯化方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0462531A2 (en) * 1990-06-18 1991-12-27 Fujisawa Pharmaceutical Co., Ltd. Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1574603A1 (ru) * 1988-08-11 1990-06-30 Ивановский Химико-Технологический Институт Способ получени мезо-тетраарилоктаметилпорфиринов
IL122315A (en) * 1992-03-19 2002-03-10 Lilly Co Eli Cyclic peptides and antifungal pharmaceutical compositions containing them

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0462531A2 (en) * 1990-06-18 1991-12-27 Fujisawa Pharmaceutical Co., Ltd. Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain

Also Published As

Publication number Publication date
NL300352I2 (nl) 2008-11-03
AR041770A1 (es) 2005-06-01
CN1203089C (zh) 2005-05-25
NO971544D0 (no) 1997-04-04
IL115484A (en) 2000-07-16
BRPI9504791B8 (pt) 2019-12-31
NO971544L (no) 1997-06-04
DE122008000025I1 (de) 2008-08-21
NO328483B1 (no) 2010-03-01
EP0788511A1 (en) 1997-08-13
DK0788511T3 (da) 2003-03-31
PT788511E (pt) 2003-04-30
US6107458A (en) 2000-08-22
US6265536B1 (en) 2001-07-24
ATE229541T1 (de) 2002-12-15
BR9504791B1 (pt) 2010-10-05
JPH10507174A (ja) 1998-07-14
MX9702531A (es) 1997-06-28
NO2010016I1 (no) 2010-08-16
LU91452I2 (fr) 2008-08-04
WO1996011210A1 (en) 1996-04-18
JP3518665B2 (ja) 2004-04-12
CN1168675A (zh) 1997-12-24
IL115484A0 (en) 1996-01-19
HUT77736A (hu) 1998-07-28
AU3578095A (en) 1996-05-02
CA2202058C (en) 2007-11-06
NL300352I1 (nl) 2008-08-01
FI971397L (fi) 1997-05-27
DE69529172D1 (de) 2003-01-23
TR199501229A2 (tr) 1996-07-21
FI971397A0 (fi) 1997-04-04
BR9504791A (pt) 1996-10-22
CA2202058A1 (en) 1996-04-18
EP0788511B1 (en) 2002-12-11
FR08C0028I2 (cg-RX-API-DMAC10.html) 2009-11-20
FI119988B (fi) 2009-05-29
RU2165423C2 (ru) 2001-04-20
JPH10324695A (ja) 1998-12-08
AU696949B2 (en) 1998-09-24
KR970707150A (ko) 1997-12-01
HK1004136A1 (en) 1998-11-20
DE69529172T2 (de) 2003-04-17
JP2897427B2 (ja) 1999-05-31
DE122008000025I2 (de) 2011-02-17
HU228151B1 (en) 2012-12-28
FR08C0028I1 (cg-RX-API-DMAC10.html) 2008-08-15
OA10475A (en) 2002-04-08
NO2010016I2 (no) 2011-10-17
ES2187575T3 (es) 2003-06-16

Similar Documents

Publication Publication Date Title
KR100353303B1 (ko) 항균활성을갖는고리형헥사펩티드
KR100396737B1 (ko) 신규 화합물
KR100346489B1 (ko) 신규한폴리펩티드화합물및이의제조방법
JP2002226500A (ja) 環状ペプチド抗真菌剤およびその製法
US20060211603A1 (en) Ramoplanin derivatives possessing antibacterial activity
US20050261177A1 (en) Compound
JP3906690B2 (ja) 環状ヘキサペプチド誘導体
US6743776B2 (en) Cyclohexapeptides having antimicrobial activity
JPH0570495A (ja) 環式ヘキサペプチド化合物
US20050181988A1 (en) Echinocandin cyclic peptide derivatives
AU756792B2 (en) New compound

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19970404

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19991124

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20020128

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20020801

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20020906

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20020909

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20050824

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20060824

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20070823

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20080825

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20090824

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20100825

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20110811

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20120821

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20120821

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20130822

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20130822

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20140825

Start annual number: 13

End annual number: 13

FPAY Annual fee payment

Payment date: 20150819

Year of fee payment: 14

PR1001 Payment of annual fee

Payment date: 20150819

Start annual number: 14

End annual number: 14

FPAY Annual fee payment

Payment date: 20160818

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 20160818

Start annual number: 15

End annual number: 15

EXPY Expiration of term
PC1801 Expiration of term